Tivozanib (KRN951) is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.
Molecular Weight:
454.86
Purity:
97.41%
CAS Number:
[475108-18-0]
Formula:
C22H19ClN4O5
Target:
PDGFR|||Ephrin Receptor|||VEGFR
T2456
* VAT and and shipping costs not included. Errors and price changes excepted